Furthermore, CD44 + CD62L − memory CD4 and CD8 T cells exhibited an increasing trend, whereas Foxp3 + regulatory CD4 T cells tended to decrease after iAB-CT26 treatment (Fig. 1 R and S and Figs.
← all excerpts
Treatment of Metastatic Cancer by Conferring Immunogenicity to the Apoptotic Bodies of the Primary Tumor.
1
—
—